Log odds of positive lymph nodes compared to positive lymph node ratio and number of positive lymph nodes in prognostic modeling for patients with NSCLC undergoing lobectomy or total pneumonectomy: a population-based study using Cox regression and XGBoost with SHAP analysis

BackgroundMethods such as the number of positive lymph nodes (nPLN), lymph node ratio (LNR), and log odds of positive lymph nodes (LODDS) are used to predict prognosis in patients with non-small cell lung cancer (NSCLC). We hypothesized that LODDS could be a superior independent predictor of prognos...

Full description

Saved in:
Bibliographic Details
Main Authors: Qiming Huang, Shai Chen, Zhenjie Li, Longren Wu, Dongliang Yu, Linmin Xiong
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Surgery
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fsurg.2024.1530250/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832593915120713728
author Qiming Huang
Shai Chen
Zhenjie Li
Longren Wu
Dongliang Yu
Linmin Xiong
author_facet Qiming Huang
Shai Chen
Zhenjie Li
Longren Wu
Dongliang Yu
Linmin Xiong
author_sort Qiming Huang
collection DOAJ
description BackgroundMethods such as the number of positive lymph nodes (nPLN), lymph node ratio (LNR), and log odds of positive lymph nodes (LODDS) are used to predict prognosis in patients with non-small cell lung cancer (NSCLC). We hypothesized that LODDS could be a superior independent predictor of prognosis and aimed to compare its effectiveness with nPLN and LNR in predicting survival outcomes in stage I-IIIA NSCLC patients.MethodsWe utilized data from the Surveillance, Epidemiology, and End Results (SEER) 17 registry (2010–2019) to study NSCLC patients, focusing on those who underwent surgery with confirmed lymph node involvement (N1 or N2 disease). We aimed to compare overall survival (OS) and cancer-specific survival (CSS) based on nPLN, LNR, and LODDS. Kaplan-Meier and Cox regression analyses were employed to evaluate survival, with thresholds determined using X-tile software. An XGBoost model was constructed to predict overall survival in patients using three features: LODDS, LNR, and PLN. SHapley Additive exPlanations (SHAP) analysis was applied to assess feature importance and provide interpretable insights into the model's predictions.ResultsThe study analyzed 3,132 eligible NSCLC patients from the SEER database, predominantly male (53.07%) with adenocarcinoma (43.65%) or squamous cell carcinoma (29.76%). Survival outcomes were assessed using nPLN, LNR, and LODDS. LODDS showed superior predictive value for both OS and CSS compared to nPLN and LNR, as indicated by a larger Log Likelihood Ratio (LLR) and smaller Akaike Information Criterion (AIC). Higher scores on npLN, LNR, and LODDS were strongly related with a poorer prognosis, according to Kaplan-Meier analyses (P < 0.001). The SHAP (SHapley Additive exPlanations) analysis of the XGBoost model demonstrated that the LODDS exhibited the highest SHAP values (0.25) for predicting overall survival in patients, consistently outperforming the LNR and the number of nPLN across both training and validation datasets.ConclusionsCompared to the nPLN and LNR staging systems, LODDS demonstrates superior prognostic power for patients with stage I–IIIA NSCLC undergoing lobectomy or pneumonectomy. By integrating both positive and negative lymph node information, LODDS offers a refined risk stratification that is particularly valuable in cases with high lymph node heterogeneity.
format Article
id doaj-art-2b3196ad8e4944409cd1927093e7162f
institution Kabale University
issn 2296-875X
language English
publishDate 2025-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Surgery
spelling doaj-art-2b3196ad8e4944409cd1927093e7162f2025-01-20T07:19:52ZengFrontiers Media S.A.Frontiers in Surgery2296-875X2025-01-011110.3389/fsurg.2024.15302501530250Log odds of positive lymph nodes compared to positive lymph node ratio and number of positive lymph nodes in prognostic modeling for patients with NSCLC undergoing lobectomy or total pneumonectomy: a population-based study using Cox regression and XGBoost with SHAP analysisQiming Huang0Shai Chen1Zhenjie Li2Longren Wu3Dongliang Yu4Linmin Xiong5Department of Cardiac Surgery, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, ChinaDepartment of Vascular Surgery, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, ChinaDepartment of Thoracic Surgery, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, ChinaDepartment of Thoracic Surgery, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, ChinaDepartment of Thoracic Surgery, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, ChinaDepartment of Thoracic Surgery, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, ChinaBackgroundMethods such as the number of positive lymph nodes (nPLN), lymph node ratio (LNR), and log odds of positive lymph nodes (LODDS) are used to predict prognosis in patients with non-small cell lung cancer (NSCLC). We hypothesized that LODDS could be a superior independent predictor of prognosis and aimed to compare its effectiveness with nPLN and LNR in predicting survival outcomes in stage I-IIIA NSCLC patients.MethodsWe utilized data from the Surveillance, Epidemiology, and End Results (SEER) 17 registry (2010–2019) to study NSCLC patients, focusing on those who underwent surgery with confirmed lymph node involvement (N1 or N2 disease). We aimed to compare overall survival (OS) and cancer-specific survival (CSS) based on nPLN, LNR, and LODDS. Kaplan-Meier and Cox regression analyses were employed to evaluate survival, with thresholds determined using X-tile software. An XGBoost model was constructed to predict overall survival in patients using three features: LODDS, LNR, and PLN. SHapley Additive exPlanations (SHAP) analysis was applied to assess feature importance and provide interpretable insights into the model's predictions.ResultsThe study analyzed 3,132 eligible NSCLC patients from the SEER database, predominantly male (53.07%) with adenocarcinoma (43.65%) or squamous cell carcinoma (29.76%). Survival outcomes were assessed using nPLN, LNR, and LODDS. LODDS showed superior predictive value for both OS and CSS compared to nPLN and LNR, as indicated by a larger Log Likelihood Ratio (LLR) and smaller Akaike Information Criterion (AIC). Higher scores on npLN, LNR, and LODDS were strongly related with a poorer prognosis, according to Kaplan-Meier analyses (P < 0.001). The SHAP (SHapley Additive exPlanations) analysis of the XGBoost model demonstrated that the LODDS exhibited the highest SHAP values (0.25) for predicting overall survival in patients, consistently outperforming the LNR and the number of nPLN across both training and validation datasets.ConclusionsCompared to the nPLN and LNR staging systems, LODDS demonstrates superior prognostic power for patients with stage I–IIIA NSCLC undergoing lobectomy or pneumonectomy. By integrating both positive and negative lymph node information, LODDS offers a refined risk stratification that is particularly valuable in cases with high lymph node heterogeneity.https://www.frontiersin.org/articles/10.3389/fsurg.2024.1530250/fulllog odds of positive lymph nodespositive lymph node rationumber of positive lymph nodesNSCLCSEER
spellingShingle Qiming Huang
Shai Chen
Zhenjie Li
Longren Wu
Dongliang Yu
Linmin Xiong
Log odds of positive lymph nodes compared to positive lymph node ratio and number of positive lymph nodes in prognostic modeling for patients with NSCLC undergoing lobectomy or total pneumonectomy: a population-based study using Cox regression and XGBoost with SHAP analysis
Frontiers in Surgery
log odds of positive lymph nodes
positive lymph node ratio
number of positive lymph nodes
NSCLC
SEER
title Log odds of positive lymph nodes compared to positive lymph node ratio and number of positive lymph nodes in prognostic modeling for patients with NSCLC undergoing lobectomy or total pneumonectomy: a population-based study using Cox regression and XGBoost with SHAP analysis
title_full Log odds of positive lymph nodes compared to positive lymph node ratio and number of positive lymph nodes in prognostic modeling for patients with NSCLC undergoing lobectomy or total pneumonectomy: a population-based study using Cox regression and XGBoost with SHAP analysis
title_fullStr Log odds of positive lymph nodes compared to positive lymph node ratio and number of positive lymph nodes in prognostic modeling for patients with NSCLC undergoing lobectomy or total pneumonectomy: a population-based study using Cox regression and XGBoost with SHAP analysis
title_full_unstemmed Log odds of positive lymph nodes compared to positive lymph node ratio and number of positive lymph nodes in prognostic modeling for patients with NSCLC undergoing lobectomy or total pneumonectomy: a population-based study using Cox regression and XGBoost with SHAP analysis
title_short Log odds of positive lymph nodes compared to positive lymph node ratio and number of positive lymph nodes in prognostic modeling for patients with NSCLC undergoing lobectomy or total pneumonectomy: a population-based study using Cox regression and XGBoost with SHAP analysis
title_sort log odds of positive lymph nodes compared to positive lymph node ratio and number of positive lymph nodes in prognostic modeling for patients with nsclc undergoing lobectomy or total pneumonectomy a population based study using cox regression and xgboost with shap analysis
topic log odds of positive lymph nodes
positive lymph node ratio
number of positive lymph nodes
NSCLC
SEER
url https://www.frontiersin.org/articles/10.3389/fsurg.2024.1530250/full
work_keys_str_mv AT qiminghuang logoddsofpositivelymphnodescomparedtopositivelymphnoderatioandnumberofpositivelymphnodesinprognosticmodelingforpatientswithnsclcundergoinglobectomyortotalpneumonectomyapopulationbasedstudyusingcoxregressionandxgboostwithshapanalysis
AT shaichen logoddsofpositivelymphnodescomparedtopositivelymphnoderatioandnumberofpositivelymphnodesinprognosticmodelingforpatientswithnsclcundergoinglobectomyortotalpneumonectomyapopulationbasedstudyusingcoxregressionandxgboostwithshapanalysis
AT zhenjieli logoddsofpositivelymphnodescomparedtopositivelymphnoderatioandnumberofpositivelymphnodesinprognosticmodelingforpatientswithnsclcundergoinglobectomyortotalpneumonectomyapopulationbasedstudyusingcoxregressionandxgboostwithshapanalysis
AT longrenwu logoddsofpositivelymphnodescomparedtopositivelymphnoderatioandnumberofpositivelymphnodesinprognosticmodelingforpatientswithnsclcundergoinglobectomyortotalpneumonectomyapopulationbasedstudyusingcoxregressionandxgboostwithshapanalysis
AT dongliangyu logoddsofpositivelymphnodescomparedtopositivelymphnoderatioandnumberofpositivelymphnodesinprognosticmodelingforpatientswithnsclcundergoinglobectomyortotalpneumonectomyapopulationbasedstudyusingcoxregressionandxgboostwithshapanalysis
AT linminxiong logoddsofpositivelymphnodescomparedtopositivelymphnoderatioandnumberofpositivelymphnodesinprognosticmodelingforpatientswithnsclcundergoinglobectomyortotalpneumonectomyapopulationbasedstudyusingcoxregressionandxgboostwithshapanalysis